Photo from Yale Cancer Center
Aug 12, 2024, 02:14
Yale Cancer Center – Lymphir offers hope for Skin Disease in cutaneous T-cell lymphoma
Yale Cancer Center shared on X:
“‘Given the long-term nature [of cutaneous T-cell lymphoma], it is vital to get skin involvement under control. Lymphir is the 1st therapeutic option in many years to offer hope of decreasing skin disease.’-Dr. Francine Foss.”
Read further.
Source: Yale Cancer Center/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 29, 2025, 16:14
Apr 29, 2025, 15:55
Apr 29, 2025, 13:57
Apr 29, 2025, 13:42
Apr 29, 2025, 12:46
Apr 29, 2025, 11:58
Apr 29, 2025, 11:21
Apr 29, 2025, 11:13